Efficacy and immunogenicity of insulin biosimilar compared to their reference products: a systematic review and meta-analysis.

Li-Jou YangTa-Wei WuChao-Hsiun TangTzu-Rong Peng

Published in: BMC endocrine disorders (2022)

Insulin biosimilar showed comparable characteristics with the reference drug in terms of efficacy, safety, immunogenicity, through comprehensive and specific conventional meta-analysis.

Keyphrases

type diabetes
systematic review
glycemic control
randomized controlled trial
metabolic syndrome
adipose tissue
drug induced
weight loss